71 – 80 of 104
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Compound genetically engineered mouse models of cancer reveal dual targeting of ALK1 and endoglin as a synergistic opportunity to impinge on angiogenic TGF-β signaling
(
- Contribution to journal › Article
-
Mark
FYN expression potentiates FLT3-ITD induced STAT5 signaling in acute myeloid leukemia.
(
- Contribution to journal › Article
-
Mark
Interferon-γ-induced p27KIP1 binds to and targets MYC for proteasome-mediated degradation.
(
- Contribution to journal › Article
-
Mark
miR-124 downregulation leads to breast cancer progression via LncRNA-MALAT1 regulation and CDK4/E2F1 signal activation.
(
- Contribution to journal › Article
-
Mark
Elevation of C-reactive protein levels in patients with transfusion-related acute lung injury
(
- Contribution to journal › Article
-
Mark
Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer
(
- Contribution to journal › Article
-
Mark
Brigatinib, an anaplastic lymphoma kinase inhibitor, abrogates activity and growth in ALK-positive neuroblastoma cells, Drosophila and mice
(
- Contribution to journal › Article
- 2015
-
Mark
BEX1 acts as a tumor suppressor in acute myeloid leukemia.
(
- Contribution to journal › Article
-
Mark
Molecular stratification of metastatic melanoma using gene expression profiling: prediction of survival outcome and benefit from molecular targeted therapy.
(
- Contribution to journal › Article
-
Mark
Frequent DPH3 promoter mutations in skin cancers.
(
- Contribution to journal › Article